Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesConneqt Health Limited

Conneqt Health Limited

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.006 AUD 0.00 ( 20.00%)
Last update at 2026-11-10T23:08:00Z
VOLUME
366750
Market Cap
5.08M

Momentum Score

…

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers. The company also provides medical and home health care devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. It sells its cardiovascular devices and services to individuals, hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025. CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.00
Low
0.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Conneqt Health Limited (ASX: CQT) is an Australia-listed company identified in public records as operating in the healthcare sector, but detailed, readily available information about its specific services, markets and operations is limited. Major long-term growth drivers are not clearly outlined in widely accessible sources, so investors should review the company's ASX disclosures and annual reports to assess revenue drivers, market position and strategic plans before drawing conclusions.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
7.90M
Revenue Per Share
0.01
Gross Profit TTM
6.21M
Debt / Equity
-
ROE
-5355.88%
Net Debt
-
ROCE
-974.07%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -18.19M -6.77M -18.89M -11.81M
Net income -18.19M -6.77M -18.89M -11.81M
Selling general administrative 14.71M 14.16M 16.23M 13.39M
Gross profit 2.56M 10.38M 3.96M 3.06M
Reconciled depreciation - - - 0.22M
Operating income -12.79M -4.36M -15.09M -12.93M
Interest expense - - - 0.23M
Tax provision - 0.00M 0.00M 0.00M
Interest income 5.40M 1.96M 0.50M 0.43M
Net interest income - - - 0.20M
Total revenue 3.55M 11.18M 4.86M 4.07M
Total operating expenses 16.35M 15.54M 19.96M -
Cost of revenue 1.00M 0.80M 0.91M 1.01M
Total other income expense net - - - 0.69M
Net income from continuing ops - - - -11.81M
Net income applicable to common shares -18.19M -6.77M -18.89M -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 9.32M 12.65M 14.54M 12.38M 11.26M
Intangible assets 0.52M 0.62M 0.63M 0.32M 0.33M
Other current assets 2.51M 4.91M 5.82M 0.75M 0.65M
Total liab 8.69M 8.56M 15.29M 5.77M 3.35M
Total stockholder equity 0.63M 4.09M -0.75M 6.61M 7.91M
Other current liab - - - 0.07M 0.28M
Common stock 102.89M 88.11M 76.62M - -
Capital stock - - - 67.55M 59.29M
Retained earnings -102.26M -84.43M -77.88M -64.87M -54.46M
Other assets 0.08M 0.04M 0.08M - -
Cash 2.43M 0.48M 0.72M 1.46M 3.67M
Total current liabilities 8.01M 8.08M 14.80M 5.12M 3.25M
Short term debt 1.08M 0.88M 1.46M - -
Short long term debt - - - 1.36M 1.26M
Other stockholder equity - 0.41M 0.52M - -
Property plant equipment 0.84M 1.22M 1.47M - -
Total current assets 7.24M 10.38M 11.84M 4.83M 9.30M
Long term investments - - - 6.16M 1.25M
Short term investments 0.00M - - 1.04M 3.53M
Net receivables 0.31M 0.35M 2.25M 0.86M 0.60M
Long term debt 0.38M - - - -
Inventory 1.99M 2.55M 1.66M 0.99M 0.44M
Accounts payable - - - 1.94M 0.78M
Non currrent assets other - - - 0.08M 0.03M
Non current assets total - - - 7.55M 1.97M
Capital lease obligations - - - 0.77M 0.18M
Long term debt total 0.67M 0.48M 0.48M - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - - - - 0.72M
Total cashflows from investing activities -0.03M -0.12M -0.08M - -
Net borrowings - - - 0.14M -0.46M
Total cash from financing activities 12.87M 7.59M 11.35M 7.41M 5.29M
Net income - - - -11.38M -5.55M
Change in cash 1.95M -0.23M -0.74M -2.18M 1.66M
Begin period cash flow - - - 3.67M 2.06M
End period cash flow - - - 1.46M 3.67M
Total cash from operating activities -10.90M -7.72M -12.00M - -
Issuance of capital stock - - - 7.60M 6.39M
Sale purchase of stock 8.55M 8.00M 9.91M -0.15M -0.33M
Other cashflows from financing activities 4.71M -0.67M -0.54M - -
Capital expenditures 0.03M 0.12M 0.08M 0.44M 0.36M
Change in working capital 0.80M 0.57M 0.36M - -
Free cash flow - - - -9.59M -4.35M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CQT
Conneqt Health Limited		 0.00
20.00%		 0.01 - - 0.64 2.75 0.84 -2.53
COH
Cochlear Ltd		 2.26
1.50%		 152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 0.06
4.72%		 1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 0.50
5.88%		 9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.11
2.13%		 5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

Conneqt Health Limited

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biomarker platform that captures a peripheral arterial waveform from the upper-arm, wrist, or finger and convert it to a central pressure waveform to extract vascular biomarkers. The company also provides medical and home health care devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders. It sells its cardiovascular devices and services to individuals, hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025. CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.

55 Lime Street, Sydney, NSW, Australia, 2000

61 2 9874 8761

https://conneqthealth.com

Name Title Year Born
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD Co-Founder & Executive Chairman 1964
Mr. Craig R. Cooper BEC, L.L.B. Co-Founder, Group CEO, MD & Executive Director 1963
Dr. Ahmad Qasem Ph.D. Chief Science & Research Officer 1964
Mr. Douglas T. Kurschinski Executive VP & Head of Global Sales for AtCor Medical Division NA
Dr. Mark Gorelick Ph.D. Chief Product Officer 1975
Ms. Catherine Liao Chief Strategy Officer 1979
Dr. Sanjeev Bhavnani Chief Clinical Officer NA
Ms. Louisa Ho Company Secretary NA
Mr. Craig R. Cooper BEC, L.L.B. Co-Founder, Group CEO, MD & Executive Director 1964
Ms. Catherine Liao Chief Strategy Officer 1980

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…